Abivax Depreciation & Amortization Growth & History (ABVX)

Abivax's depreciation and amortization was €1.1M for fiscal 2025.

View full Abivax company overview

Abivax annual depreciation and amortization history

Abivax annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31€1.1M−€28,000−2.55%
20242024-12-31€1.1M€393,000+55.59%
20232023-12-31€707,000€222,000+45.77%
20222022-12-31€485,000€183,000+60.60%
20212021-12-31€302,000

Abivax depreciation and amortization trends

Between the periods ended 2021-12-31 and 2025-12-31, Abivax's depreciation and amortization increased from €302,000 to €1.1M, a change of €770,000. The latest reported quarter, Q1 2026, shows €367,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Abivax source filings ↗

Community posts

It’s quiet here.

No posts about ABVX yet. Start the conversation.

Write the first post